|
MiCheck performance: Comparator trial of MiCheck with PHI, % free PSA and PSA—The impact on decision making for prostate biopsy. |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Myovant Sciences; Pfizer; Tolmar |
Speakers' Bureau - Bayer; Dendreon; Janssen |
|
|
Consulting or Advisory Role - Astellas Medivation; Janssen |
Speakers' Bureau - Astellas Medivation; Janssen |
|
Christopher Michael Pieczonka |
No Relationships to Disclose |
|
Jennifer Lynn Beebe-Dimmer |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - Minomic |
Research Funding - Minomic |
Patents, Royalties, Other Intellectual Property - Minomic |
Travel, Accommodations, Expenses - Minomic |
|
|
No Relationships to Disclose |